Firearms dealers from across Northern Ireland discussed proposals to significantly increase firearms licensing fees in the Province at a meeting organised by BASC NI.
Responding to MPs’ rejection of the House of Lords’ amendments to the Welfare Reform Bill in the House of Commons today (Wednesday 1 February 2012), Liz Carroll, Director of Policy and Research at Breast Cancer Care said:
Breast Cancer Care is publishing recommendations on how to improve outcomes and experiences for older women with breast cancer in a new policy briefing, supported by Age UK.
Breast Cancer Care, the leading breast cancer support and information charity in the UK, has produced a new report, backed by Age UK, that makes clear recommendations to improve outcomes and experiences for older women with breast cancer, a demographic proven to have poorer relative survival rates and an increased likelihood of presenting later with symptoms and of receiving non-standard treatments.
Commenting on NICE's recommendation on bevacizumab (Avastin), Dr Emma Pennery, Clinical Director at Breast Cancer Care said.
The results of this large-scale study are very reassuring as they confirm that current NICE guidance1 , which recommends annual mammograms for women over 40 who are at an increased risk of breast cancer, is effective.
Commenting on research from Phillipe Autier et al published in the BMJ online which claims that UK breast cancer mortality rates have fallen faster than other EU countries.
Commenting on the publication of the coalition government's NHS white paper today, Samia al Qadhi, Chief Executive of Breast Cancer Care said.
Commenting on research, to be published in the July issue of The Oncologist, looking at discrimination in treatment of older women with breast cancer.
Breast Cancer Care has been nominated for a major national prize at The Charity Awards 2010 - the UK charity sector's most prestigious awards scheme.
Jane Hatfield, Director of Policy and Research at Breast Cancer Care comments on new cancer survival rates issued by the Office for National Statistics.
From the number of calls we receive to our helpline, we know that the ongoing debate around the effectiveness of screening can cause confusion and anxiety for women.
Statement from Breast Cancer Care on research presented by Dr Azim at the seventh European Breast Cancer Conference which suggests that pregnancy does not increase the risk of recurrence in women who have had breast cancer.
Statement from Breast Cancer Care on research presented by Heemskerk-Gerritsen and Pierce at the seventh European Breast Cancer Conference on surgical options for patients with inherited breast cancer.
Statement from Breast Cancer Care on research from the Queen's Medical Centre, Nottingham, presented to the seventh European Breast Cancer Conference on the use of beta-blockers to help reduce metastasis and improve survival in breast cancer patients.
Statement from Breast Cancer Care on research from the University of Frankfurt presented to the European Breast Cancer Conference which suggests that pregnant women can receive chemotherapy for breast cancer without endangering the health of their babies.
Statement from Breast Cancer Care on research from the Leiden University Medical Centre presented to the European Breast Cancer Conference which suggests that women from lower socioeconomic groups have a poorer breast cancer survival rates
A diagnosis of breast cancer brings a complex range of emotional and practical concerns, and being unable to access necessary drugs can only cause extra anxiety at an already difficult time.
Statement from Breast Cancer Care on research from the University of Dundee that establishes a link between deprivation and the p53 gene to explain why women from poorer backgrounds are less likely to survive breast cancer.
Statement from Breast Cancer Care on research published in the BMJ looking at the effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer.
It is extremely encouraging to see a significant increase in the number of women accepting their invitations to breast screening.
These proposals will give breast cancer patients clarity on how quickly they can expect to seen. The pledge to reduce waiting times is extremely welcome as we know that unnecessary waiting can cause great anxiety for patients and their families.
Maria Leadbeater, Clinical Nurse Specialist at Breast Cancer Care, said: "This small study provides a unique retrospective insight into the link between breast density and risk of recurrence after breast conserving surgery.
Jane Hatfield, Director of Policy and Campaigns at Breast Cancer Care, said: "There has been some improvement in the number of women offered immediate reconstruction since the first annual audit, however it is unacceptable that the majority are still not given this option."
We know from the volume of calls that we receive to our helpline that women are keen to understand the contribution their lifestyle can make to their own risk of developing breast cancer.